Artificial Intelligence (AI) is playing an increasingly significant role in scientific research and development (R&D), particularly within the biopharmaceutical...

Daiichi Sankyo is committed to addressing neglected needs in cardiovascular care, highlighting disparities in treatment and outcomes between different...

Traditionally regarded as a cornerstone of global innovation, the pharmaceutical industry now faces unprecedented challenges, prompting even the largest...

Median Technologies’ eyonis™ LCS, an AI-powered SaMD for lung cancer screening, has demonstrated strong performance in its REALITY pivotal...

Merck has discontinued two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630. The KEYNOTE-867 trial evaluated the combination of KEYTRUDA (pembrolizumab)...

During the 2024 European Society of Cardiology (ESC) Congress, Bayer will unveil late-breaking results from the Phase III FINEARTS-HF...

Elastin Biosciences is at the forefront of developing small molecule therapies for elastin restoration. Their innovative approach aims to...

Statistics & Data Corporation (SDC), a pioneer in clinical trial biometrics, has unveiled its groundbreaking Bring Your Own Device...

Merck has launched Shorespan-007, a Phase 3 clinical trial evaluating bomedemstat for treating patients with essential thrombocythemia (ET) who...

In this interview, Tim Smith, CTO and co-founder of Medable, discusses the launch of Medable Studio, a no-code platform...